PharmTech
CONTINUE TO SITE >

OR WAIT 15 SECS

ISPE Announces 2020–2021 International Board of Directors

November 11, 2020
Pharmaceutical Technology Editors

ISPE announced its 2020–2021 International Board of Directors during the virtual 2020 ISPE Annual Meeting & Expo on Nov. 6, 2020.

The International Society for Pharmaceutical Engineering (ISPE) announced its 2020–2021 International Board of Directors during the virtual 2020 ISPE Annual Meeting & Expo on Nov. 6, 2020.

According to an ISPE press release, the new board consists of:

Officers:

  • Chair: Joanne Barrick, RPh, Advisor, Global Validation, Eli Lilly and Company
  • Vice Chair: Jörg Zimmermann, vice president, Vetter Development Service, External Affairs, Vetter Pharma Fertigung GmbH&Co KG
  • Treasurer: Michael Rutherford, executive director, Computer Systems Quality & Data Integrity, Syneos Health
  • Secretary: Scott Billman, global head of Engineering, Biogen
  • Past Chair: Frances Zipp, president and CEO, Lachman Consultant Services, Inc.

Directors Elected to a Second Term:

  • Vivianne Arencibia, independent consultant, Arencibia Quality Compliance Associates
  • Chris Chen, PhD, CEO, WuXi Biologics (Shanghai) Co., Ltd.

New Directors:

  • Nina Cauchon, PhD, director, Regulatory Affairs - CMC, Amgen Inc.
  • David Doleski, compliance head for Biologics Quality Operations, Sanofi (Appointed director)
  • Teresa Minero, founder and CEO, LifeBee - Digitalizing Life Sciences
  • Hirofumi Suzuki, PhD, senior regulatory CMC adviser, Bayer Yakuhin Ltd

Continuing Board Members:

  • Ylva Ek, chief quality officer, KeyPlants AB
  • Lou Kennedy, CEO and owner, Nephron Pharmaceuticals
  • Stephen Mahoney, JD, senior director, Global Quality & Compliance, Genentech, a member of the Roche Group
  • Alice Redmond, PhD, vice president, European Operations, CAI

Young Professionals Representative (Ex Officio):

  • John Clarke, operations lead, Pfizer

Source: ISPE